/Lists

Longevity Investors & VC Firms in United States

202 firms in this list, with a median first check of $350K. 53 of them lead rounds. Generated from verified public data and updated continuously.

Hartmann Capital
MiamiPre-Seed–Seed$300K – $3M
10 people
Primetime Partners
New YorkSeed–Series A$250K – $1M
13 people
Future Ventures
Los AltosPre-Seed–Series A$1M – $10M
4 people
SteelSky Ventures
AtlantaSeed$100K – $5M
11 people
Elad Gil
San FranciscoSeed–Growth$100K – $10M
1 person
Revelation Partners
SausalitoGrowth–Late Stage$5M – $50M
15 people
Ventas
Chicago
30 people
Civilization Ventures Management, Llc
TiburonPre-Seed–Growth$1M – $10M
4 people
LYFE Capital
Menlo ParkSeed–Late Stage
22 people
Able Partners
New YorkPre-Seed–Series A$500K – $3M
3 people
ECP Growth
GreenwichGrowth
15 people
Lauder Partners
Los AltosSeries B
1 person
Merck Global Health Innovation Fund
RahwaySeed–Growth$10M
10 people
O2h Ventures
CambridgeSeed–Series A
23 people
Taihill Venture
CambridgePre-Seed–Seed
11 people
Qiming Venture Partners USA
CambridgeSeed–Series B
19 people
Westlake Village BioPartners
Los AngelesPre-Seed–Series A$100K – $5M
13 people
Black Jays Ventures
New YorkPre-Seed–Seed$250K – $500K
4 people
Maven Ventures
Palo AltoSeed$1M
4 people
Spero Ventures
BurlingameSeed–Series A$2M – $4M
6 people
DCVC Bio
Palo AltoSeed–Growth
14 people
Medical Excellence Capital
New YorkSeed–Series B
19 people
Catalytic Impact Foundation
HinghamPre-Seed–Series A
8 people
WMU Biosciences Research & Commercialization Center
KalamazooSeed–Series A$100K – $250K
12 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.